Target Audience and Goal Statement
This activity is intended for electrophysiologists, interventional cardiologists, and clinical cardiologists.
The goal of this activity is to inform physicians on management strategies for patients at risk for sudden cardiac death when
an ICD is not an option.
Upon completion of this activity, participants will be able to:
- Discuss how to better manage and protect patients in the 90-day period post-MI
- Review actionable data to consider in that period based on patient characteristics and how to implement into clinical practice
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator(s)

-
Rahul N. Doshi, MD
Assistant Professor of Medicine, University of California at Irvine; Director, Electrophysiology, University of California
at Irvine Medical Center, St. Jude Medical Center, Irvine, California
Disclosures
Disclosure: Rahul N. Doshi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: St. Jude Medical
Served as a speaker or a member of a speakers bureau for: Boston Scientific; St. Jude Medical
Dr Doshi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Doshi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Panelist(s)

-
James L. Januzzi, MD
Hutter family Professor of Medicine, Harvard Medical School; Roman W. DeSanctis Endowed Clinical Scholar, Massachusetts General
Hospital, Boston, Massachusetts
Disclosures
Disclosure: James L. Januzzi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Critical Diagnostics; Roche; sphingotec GmbH
Received grants for clinical research from: Siemens AG; Singulex; Thermo Fisher Scientific Inc.
Dr Januzzi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Januzzi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
Sunil V. Rao, MD
Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Lab, Durham VA Medical
Center, Durham, North Carolina
Disclosures
Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Medtronic, Inc.; Terumo Medical Corporation; The Medicines Company
Served as a speaker or a member of a speaker’s bureau for: Medtronic, Inc.
Received grants for clinical research from: Bellerophon Therapeutics
Dr Rao does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Rao does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
Ulrika Birgersdotter-Green, MD
Professor of Medicine; Director, Pacemaker and ICD Services, University of California, San Diego, California
Disclosures
Disclosure: Ulrika Birgersdotter-Green, MD, has disclosed the following relevant financial relationships:
Served as an advisor or a member of a speakers bureau for: Boston Scientific; Medtronic, Inc.; St. Jude Medical
Dr Birgersdotter-Green does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Birgersdotter-Green does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editor(s)
CME Reviewer(s)
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.